Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 7/20 | 0.68 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | PTPRF | P10586 | 1/20 | 0.56 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19006636 | 0.95 | FFAR1 (0.73) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL5362592 | 0.91 | FFAR1 (0.68) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL2065031 | 0.91 | CYP1A2 (0.69) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL10756655 | 0.88 | HTT (0.69) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL25760803 | 0.88 | FFAR1 (0.63) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL17448681 | 0.88 | HTT (0.75) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL19091942 | 0.86 | FFAR1 (0.63) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL11512045 | 0.86 | HTT (0.79) | FFAR1FFAR4MEN1KMT2ACYP1A2 | |
| SCHEMBL11509316 | 0.86 | FFAR1 (0.68) | FFAR1FFAR4MEN1KMT2AHTT | |
| SCHEMBL11510992 | 0.86 | FFAR1 (0.63) | FFAR1FFAR4MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114340636-A | Method of treatment | 细胞内治疗公司 | 2022-04-12 | — | — | CN | claimed |
| CN-113194955-A | New use | 细胞内治疗公司 | 2021-07-30 | — | — | CN | claimed |
| CN-112189013-A | Organic compounds | 细胞内治疗公司 | 2021-01-05 | — | — | CN | claimed |
| CN-102238872-A | Organic compounds | INTRA CELLULAR THERAPIES INC | 2011-11-09 | — | — | CN | claimed |
| CN-102232077-A | Organic compounds | INTRA CELLULAR THERAPIES INC | 2011-11-02 | — | — | CN | claimed |
| CN-102231953-A | Organic compounds | INTRA CELLULAR THERAPIES INC | 2011-11-02 | — | — | CN | claimed |
| WO-2023096225-A1 | HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER, COMPRISING SAME | 엘티소재주식회사 | 2023-06-01 | — | — | WO | disclosed |
| CN-115925555-A | Selective hydrogenation reduction method of alpha, beta-unsaturated imine | 化学与精细化工广东省实验室 | 2023-04-07 | — | — | CN | disclosed |
| CN-114340636-A | Method of treatment | 细胞内治疗公司 | 2022-04-12 | — | — | CN | disclosed |
| US-11214538-B2 | Farnesoid X receptor agonists and uses thereof | METACRINE, INC. (US) | 2022-01-04 | — | — | US | disclosed |
| CN-113194955-A | New use | 细胞内治疗公司 | 2021-07-30 | — | — | CN | disclosed |
| US-20210032195-A1 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | ELI LILLY AND COMPANY | 2021-02-04 | — | — | US | disclosed |
| CN-112189013-A | Organic compounds | 细胞内治疗公司 | 2021-01-05 | — | — | CN | disclosed |
| US-5015762-A | Alkoxy substituted ureas as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | disclosed |
| EP-0041145-B1 | ARALKYL-PHENYL UREAS AND THEIR HERBICIDAL COMPOSITIONS | BASF Aktiengesellschaft (DE) | 1984-12-19 | — | — | EP | disclosed |
| US-4422871-A | Aralkylphenylureas and herbicides containing these | BASF AKTIENGESELLSCHAFT (DE) | 1983-12-27 | — | — | US | disclosed |
| EP-0041145-A2 | Aralkyl-phenyl ureas and their herbicidal compositions | BASF Aktiengesellschaft (DE) | 1981-12-09 | — | — | EP | disclosed |
| US-4152452-A | N-BENZYLANILINE AND DERIVATIVES | WILLIAM H. RORER, INC. (US) | 1979-05-01 | — | — | US | disclosed |
| US-4076530-A | Dry photographic copying method for producing Te images | FUJI PHOTO FILM CO., LTD. (JA) | 1978-02-28 | — | — | US | disclosed |
| US-4062685-A | ORGANO-TELLURIUM COMPOUND | FUJI PHOTO FILM CO., LTD. (JA) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032195-A1 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | NR1H4, NR1H2, NR1H3 | FFAR1 45/4885FFAR4 57/4885MEN1 2725/4885 |
| US-11214538-B2 | Farnesoid X receptor agonists and uses thereof | NR1H4, NR1H2, NR1H3 | FFAR1 45/4885FFAR4 57/4885MEN1 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.